Name | Number of supported studies | Average coverage | |
---|---|---|---|
erythrocyte | 3 studies | 27% ± 10% | |
hematopoietic precursor cell | 3 studies | 32% ± 13% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 41% ± 24% | |
natural killer cell | 3 studies | 24% ± 8% | |
CD8-positive, alpha-beta T cell | 3 studies | 18% ± 1% |
Insufficient scRNA-seq data for expression of MCM2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 807.65 | 180 / 180 | 97% | 47.06 | 417 / 430 |
uterus | 100% | 792.08 | 170 / 170 | 93% | 68.12 | 427 / 459 |
skin | 100% | 2036.05 | 1809 / 1809 | 93% | 27.49 | 437 / 472 |
esophagus | 95% | 861.52 | 1374 / 1445 | 97% | 46.57 | 177 / 183 |
intestine | 98% | 836.99 | 945 / 966 | 94% | 35.78 | 495 / 527 |
stomach | 93% | 555.85 | 333 / 359 | 96% | 34.93 | 274 / 286 |
breast | 97% | 634.65 | 444 / 459 | 90% | 27.08 | 1007 / 1118 |
bladder | 100% | 613.33 | 21 / 21 | 86% | 33.32 | 431 / 504 |
lung | 92% | 655.59 | 533 / 578 | 90% | 38.15 | 1037 / 1155 |
thymus | 100% | 779.37 | 650 / 653 | 75% | 13.49 | 453 / 605 |
prostate | 98% | 642.63 | 241 / 245 | 68% | 9.22 | 342 / 502 |
brain | 91% | 447.49 | 2399 / 2642 | 66% | 16.18 | 465 / 705 |
pancreas | 84% | 288.81 | 276 / 328 | 64% | 11.09 | 114 / 178 |
kidney | 88% | 464.84 | 78 / 89 | 50% | 6.68 | 455 / 901 |
adrenal gland | 95% | 585.04 | 245 / 258 | 22% | 2.74 | 50 / 230 |
spleen | 100% | 1706.79 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 115.84 | 45 / 45 |
muscle | 99% | 728.30 | 794 / 803 | 0% | 0 | 0 / 0 |
adipose | 96% | 493.93 | 1154 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 357.76 | 1239 / 1335 | 0% | 0 | 0 / 0 |
liver | 47% | 273.44 | 107 / 226 | 45% | 8.89 | 183 / 406 |
heart | 90% | 441.66 | 773 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 51.04 | 25 / 29 |
peripheral blood | 85% | 3974.28 | 790 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 8.42 | 55 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006268 | Biological process | DNA unwinding involved in DNA replication |
GO_0071353 | Biological process | cellular response to interleukin-4 |
GO_0006260 | Biological process | DNA replication |
GO_0006334 | Biological process | nucleosome assembly |
GO_0000727 | Biological process | double-strand break repair via break-induced replication |
GO_0090102 | Biological process | cochlea development |
GO_0006270 | Biological process | DNA replication initiation |
GO_0030174 | Biological process | regulation of DNA-templated DNA replication initiation |
GO_0006915 | Biological process | apoptotic process |
GO_1902975 | Biological process | mitotic DNA replication initiation |
GO_0005730 | Cellular component | nucleolus |
GO_0005664 | Cellular component | nuclear origin of replication recognition complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0042555 | Cellular component | MCM complex |
GO_0071162 | Cellular component | CMG complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0042393 | Molecular function | histone binding |
GO_0003688 | Molecular function | DNA replication origin binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0017116 | Molecular function | single-stranded DNA helicase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0043138 | Molecular function | 3'-5' DNA helicase activity |
Gene name | MCM2 |
Protein name | DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28) DNA replication licensing factor MCM2 (EC 3.6.4.12) Minichromosome maintenance complex component 2 DNA helicase (EC 3.6.4.12) |
Synonyms | KIAA0030 BM28 CCNL1 CDCL1 |
Description | FUNCTION: Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built . The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity . Required for the entry in S phase and for cell division . Plays a role in terminally differentiated hair cells development of the cochlea and induces cells apoptosis . . |
Accessions | C9J013 ENST00000474964.5 C9JZ21 ENST00000491422.1 H7C4N9 ENST00000265056.12 ENST00000480910.1 ENST00000477668.5 ENST00000472731.1 H0Y8E6 F8WDM3 P49736 Q9BWF4 |